Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic.

CYP2D6 testing to predict response to tamoxifen in women with breast cancer: Pharmacogenomic. PLoS Curr. 2010 Sep 02; 2:RRN1176.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.